In conclusion, although AFP is not commonly used as a biomarker in routine lung cancer diagnosis, it may act as a key diagnostic indicator in certain subtypes and play a supportive role in predicting metastasis and assessing tumor progression. Here, AFP is linked to lung carcinoma.